APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrinology Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Endocrinology Drugs Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchEndocrinology Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrinology Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Endocrinology Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrinology Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrinology Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Endocrinology Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Endocrinology Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Endocrinology Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Endocrinology Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Endocrinology Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Endocrinology Drugs include Sanofi, Novo Nordisk, Merck, Eli Lilly, AbbVie and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Endocrinology Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Endocrinology Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Endocrinology Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endocrinology Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endocrinology Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Endocrinology Drugs sales, projected growth trends, production technology, application and end-user industry.

Endocrinology Drugs Segment by Company

Sanofi

Novo Nordisk

Merck

Eli Lilly

AbbVie

AstraZeneca

Endocrinology Drugs Segment by Type

Diabetes Drugs

Human Growth Hormone Drugs

Thyroid Hormone Disorder Drugs

Testosterone Replacement Drugs

Endocrinology Drugs Segment by Application

Ambulatory Care Centres

Commercial Laboratories

Hospitals

Other Setting

Endocrinology Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrinology Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrinology Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrinology Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Endocrinology Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Endocrinology Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endocrinology Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Endocrinology Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diabetes Drugs Major Manufacturers Table 3. Human Growth Hormone Drugs Major Manufacturers Table 4. Thyroid Hormone Disorder Drugs Major Manufacturers Table 5. Testosterone Replacement Drugs Major Manufacturers Table 6. Global Endocrinology Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Ambulatory Care Centres Major Manufacturers Table 8. Commercial Laboratories Major Manufacturers Table 9. Hospitals Major Manufacturers Table 10. Other Setting Major Manufacturers Table 11. Endocrinology Drugs Industry Trends Table 12. Endocrinology Drugs Industry Drivers Table 13. Endocrinology Drugs Industry Opportunities and Challenges Table 14. Endocrinology Drugs Industry Restraints Table 15. Global Endocrinology Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Endocrinology Drugs Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Endocrinology Drugs Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Endocrinology Drugs Revenue Market Share by Region (2021-2026) Table 19. Global Endocrinology Drugs Revenue Market Share by Region (2027-2032) Table 20. Global Endocrinology Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Endocrinology Drugs Sales by Region (2021-2026) & (k units) Table 22. Global Endocrinology Drugs Sales by Region (2027-2032) & (k units) Table 23. Global Endocrinology Drugs Sales Market Share by Region (2021-2026) Table 24. Global Endocrinology Drugs Sales Market Share by Region (2027-2032) Table 25. Global Endocrinology Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Endocrinology Drugs Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Endocrinology Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Endocrinology Drugs Sales Market Share by Manufacturers (2021-2026) Table 29. Global Endocrinology Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Endocrinology Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Endocrinology Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Endocrinology Drugs Manufacturers, Product Type & Application Table 33. Global Endocrinology Drugs Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Endocrinology Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Endocrinology Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Endocrinology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Endocrinology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Endocrinology Drugs Revenue Market Share by Type (2021-2026) Table 40. Global Endocrinology Drugs Revenue Market Share by Type (2027-2032) Table 41. Global Endocrinology Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 43. Global Endocrinology Drugs Sales by Type (2027-2032) & (k units) Table 44. Global Endocrinology Drugs Sales Market Share by Type (2021-2026) Table 45. Global Endocrinology Drugs Sales Market Share by Type (2027-2032) Table 46. Global Endocrinology Drugs Price by Type (2021-2026) & (US$/unit) Table 47. Global Endocrinology Drugs Price by Type (2027-2032) & (US$/unit) Table 48. Global Endocrinology Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Endocrinology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Endocrinology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Endocrinology Drugs Revenue Market Share by Application (2021-2026) Table 52. Global Endocrinology Drugs Revenue Market Share by Application (2027-2032) Table 53. Global Endocrinology Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 55. Global Endocrinology Drugs Sales by Application (2027-2032) & (k units) Table 56. Global Endocrinology Drugs Sales Market Share by Application (2021-2026) Table 57. Global Endocrinology Drugs Sales Market Share by Application (2027-2032) Table 58. Global Endocrinology Drugs Price by Application (2021-2026) & (US$/unit) Table 59. Global Endocrinology Drugs Price by Application (2027-2032) & (US$/unit) Table 60. Sanofi Company Information Table 61. Sanofi Business Overview Table 62. Sanofi Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Sanofi Endocrinology Drugs Product Portfolio Table 64. Sanofi Recent Development Table 65. Novo Nordisk Company Information Table 66. Novo Nordisk Business Overview Table 67. Novo Nordisk Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Novo Nordisk Endocrinology Drugs Product Portfolio Table 69. Novo Nordisk Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Merck Endocrinology Drugs Product Portfolio Table 74. Merck Recent Development Table 75. Eli Lilly Company Information Table 76. Eli Lilly Business Overview Table 77. Eli Lilly Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Eli Lilly Endocrinology Drugs Product Portfolio Table 79. Eli Lilly Recent Development Table 80. AbbVie Company Information Table 81. AbbVie Business Overview Table 82. AbbVie Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. AbbVie Endocrinology Drugs Product Portfolio Table 84. AbbVie Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca Endocrinology Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. AstraZeneca Endocrinology Drugs Product Portfolio Table 89. AstraZeneca Recent Development Table 90. North America Endocrinology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Endocrinology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 93. North America Endocrinology Drugs Sales by Type (2027-2032) & (k units) Table 94. North America Endocrinology Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 95. North America Endocrinology Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 96. North America Endocrinology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 97. North America Endocrinology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 98. North America Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 99. North America Endocrinology Drugs Sales by Application (2027-2032) & (k units) Table 100. North America Endocrinology Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 101. North America Endocrinology Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 102. North America Endocrinology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Endocrinology Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. North America Endocrinology Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. North America Endocrinology Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 106. North America Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 107. North America Endocrinology Drugs Sales by Country (2027-2032) & (k units) Table 108. North America Endocrinology Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 109. North America Endocrinology Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 110. United States Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 111. Canada Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 112. Mexico Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 113. Europe Endocrinology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 114. Europe Endocrinology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 115. Europe Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 116. Europe Endocrinology Drugs Sales by Type (2027-2032) & (k units) Table 117. Europe Endocrinology Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 118. Europe Endocrinology Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 119. Europe Endocrinology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Endocrinology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 122. Europe Endocrinology Drugs Sales by Application (2027-2032) & (k units) Table 123. Europe Endocrinology Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 124. Europe Endocrinology Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 125. Europe Endocrinology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Endocrinology Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. Europe Endocrinology Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. Europe Endocrinology Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 129. Europe Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 130. Europe Endocrinology Drugs Sales by Country (2027-2032) & (k units) Table 131. Europe Endocrinology Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 132. Europe Endocrinology Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 133. Germany Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 134. France Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 135. U.K. Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 136. Italy Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 137. Russia Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 138. Spain Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 139. Netherlands Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 140. Switzerland Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 141. Sweden Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 142. Poland Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 143. China Endocrinology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 144. China Endocrinology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 145. China Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 146. China Endocrinology Drugs Sales by Type (2027-2032) & (k units) Table 147. China Endocrinology Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 148. China Endocrinology Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 149. China Endocrinology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 150. China Endocrinology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 151. China Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 152. China Endocrinology Drugs Sales by Application (2027-2032) & (k units) Table 153. China Endocrinology Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 154. China Endocrinology Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 155. Asia Endocrinology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 156. Asia Endocrinology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 157. Asia Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 158. Asia Endocrinology Drugs Sales by Type (2027-2032) & (k units) Table 159. Asia Endocrinology Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 160. Asia Endocrinology Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 161. Asia Endocrinology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 162. Asia Endocrinology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 163. Asia Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 164. Asia Endocrinology Drugs Sales by Application (2027-2032) & (k units) Table 165. Asia Endocrinology Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 166. Asia Endocrinology Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 167. Asia Endocrinology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Asia Endocrinology Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Asia Endocrinology Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Asia Endocrinology Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 171. Asia Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 172. Asia Endocrinology Drugs Sales by Country (2027-2032) & (k units) Table 173. Asia Endocrinology Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 174. Asia Endocrinology Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 175. Japan Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 176. South Korea Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 177. India Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 178. Australia Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 179. Taiwan Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 180. Southeast Asia Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 181. SAMEA Endocrinology Drugs Revenue by Type (2021-2026) & (US$ Million) Table 182. SAMEA Endocrinology Drugs Revenue by Type (2027-2032) & (US$ Million) Table 183. SAMEA Endocrinology Drugs Sales by Type (2021-2026) & (k units) Table 184. SAMEA Endocrinology Drugs Sales by Type (2027-2032) & (k units) Table 185. SAMEA Endocrinology Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 186. SAMEA Endocrinology Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 187. SAMEA Endocrinology Drugs Revenue by Application (2021-2026) & (US$ Million) Table 188. SAMEA Endocrinology Drugs Revenue by Application (2027-2032) & (US$ Million) Table 189. SAMEA Endocrinology Drugs Sales by Application (2021-2026) & (k units) Table 190. SAMEA Endocrinology Drugs Sales by Application (2027-2032) & (k units) Table 191. SAMEA Endocrinology Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 192. SAMEA Endocrinology Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 193. SAMEA Endocrinology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. SAMEA Endocrinology Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. SAMEA Endocrinology Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. SAMEA Endocrinology Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 197. SAMEA Endocrinology Drugs Sales by Country (2021-2026) & (k units) Table 198. SAMEA Endocrinology Drugs Sales by Country (2027-2032) & (k units) Table 199. SAMEA Endocrinology Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 200. SAMEA Endocrinology Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 201. Brazil Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 202. Argentina Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 203. Chile Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 204. Colombia Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 205. Peru Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 206. Saudi Arabia Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 207. Israel Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 208. UAE Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 209. Turkey Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 210. Iran Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 211. Egypt Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Endocrinology Drugs Distributors List Table 215. Endocrinology Drugs Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Endocrinology Drugs Image Figure 2. Global Endocrinology Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrinology Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diabetes Drugs Image Figure 5. Human Growth Hormone Drugs Image Figure 6. Thyroid Hormone Disorder Drugs Image Figure 7. Testosterone Replacement Drugs Image Figure 8. Global Endocrinology Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Endocrinology Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 10. Ambulatory Care Centres Image Figure 11. Commercial Laboratories Image Figure 12. Hospitals Image Figure 13. Other Setting Image Figure 14. Global Endocrinology Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Endocrinology Drugs Revenue (2021-2032) & (US$ Million) Figure 16. Global Endocrinology Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Endocrinology Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Endocrinology Drugs Revenue Market Share by Region (2021-2032) Figure 19. Global Endocrinology Drugs Sales (2021-2032) & (k units) Figure 20. Global Endocrinology Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Endocrinology Drugs Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Endocrinology Drugs Sales YoY (2021-2032) & (k units) Figure 23. Europe Endocrinology Drugs Sales YoY (2021-2032) & (k units) Figure 24. China Endocrinology Drugs Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Endocrinology Drugs Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Endocrinology Drugs Sales YoY (2021-2032) & (k units) Figure 27. Global Endocrinology Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Endocrinology Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Endocrinology Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Endocrinology Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Endocrinology Drugs Revenue Market Share by Type (2021-2032) Figure 33. Global Endocrinology Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Endocrinology Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Endocrinology Drugs Sales Market Share by Type (2021-2032) Figure 36. Global Endocrinology Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Endocrinology Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Endocrinology Drugs Revenue Market Share by Application (2021-2032) Figure 39. Global Endocrinology Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Endocrinology Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Endocrinology Drugs Sales Market Share by Application (2021-2032) Figure 42. North America Endocrinology Drugs Revenue Share by Type (2021-2032) Figure 43. North America Endocrinology Drugs Sales Share by Type (2021-2032) Figure 44. North America Endocrinology Drugs Revenue Share by Application (2021-2032) Figure 45. North America Endocrinology Drugs Sales Share by Application (2021-2032) Figure 46. North America Endocrinology Drugs Revenue Share by Country (2021-2032) Figure 47. North America Endocrinology Drugs Sales Share by Country (2021-2032) Figure 48. Europe Endocrinology Drugs Revenue Share by Type (2021-2032) Figure 49. Europe Endocrinology Drugs Sales Share by Type (2021-2032) Figure 50. Europe Endocrinology Drugs Revenue Share by Application (2021-2032) Figure 51. Europe Endocrinology Drugs Sales Share by Application (2021-2032) Figure 52. Europe Endocrinology Drugs Revenue Share by Country (2021-2032) Figure 53. Europe Endocrinology Drugs Sales Share by Country (2021-2032) Figure 54. China Endocrinology Drugs Revenue Share by Type (2021-2032) Figure 55. China Endocrinology Drugs Sales Share by Type (2021-2032) Figure 56. China Endocrinology Drugs Revenue Share by Application (2021-2032) Figure 57. China Endocrinology Drugs Sales Share by Application (2021-2032) Figure 58. Asia Endocrinology Drugs Revenue Share by Type (2021-2032) Figure 59. Asia Endocrinology Drugs Sales Share by Type (2021-2032) Figure 60. Asia Endocrinology Drugs Revenue Share by Application (2021-2032) Figure 61. Asia Endocrinology Drugs Sales Share by Application (2021-2032) Figure 62. Asia Endocrinology Drugs Revenue Share by Country (2021-2032) Figure 63. Asia Endocrinology Drugs Sales Share by Country (2021-2032) Figure 64. SAMEA Endocrinology Drugs Revenue Share by Type (2021-2032) Figure 65. SAMEA Endocrinology Drugs Sales Share by Type (2021-2032) Figure 66. SAMEA Endocrinology Drugs Revenue Share by Application (2021-2032) Figure 67. SAMEA Endocrinology Drugs Sales Share by Application (2021-2032) Figure 68. SAMEA Endocrinology Drugs Revenue Share by Country (2021-2032) Figure 69. SAMEA Endocrinology Drugs Sales Share by Country (2021-2032) Figure 70. Endocrinology Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Endocrinology Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Diabetes Drugs
  • Human Growth Hormone Drugs
  • Thyroid Hormone Disorder Drugs
  • Testosterone Replacement Drugs
Applications
  • Ambulatory Care Centres
  • Commercial Laboratories
  • Hospitals
  • Other Setting
Companies covered
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • AbbVie
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Endocrinology Drugs Market by Type
  3. 1.2.1 Global Endocrinology Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diabetes Drugs
  5. 1.2.3 Human Growth Hormone Drugs
  6. 1.2.4 Thyroid Hormone Disorder Drugs
  7. 1.2.5 Testosterone Replacement Drugs
  8. 1.3 Endocrinology Drugs Market by Application
  9. 1.3.1 Global Endocrinology Drugs Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Ambulatory Care Centres
  11. 1.3.3 Commercial Laboratories
  12. 1.3.4 Hospitals
  13. 1.3.5 Other Setting
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Endocrinology Drugs Market Dynamics
  1. 2.1 Endocrinology Drugs Industry Trends
  2. 2.2 Endocrinology Drugs Industry Drivers
  3. 2.3 Endocrinology Drugs Industry Opportunities and Challenges
  4. 2.4 Endocrinology Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Endocrinology Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Endocrinology Drugs Revenue by Region
  3. 3.2.1 Global Endocrinology Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Endocrinology Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Endocrinology Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Endocrinology Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Endocrinology Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Endocrinology Drugs Sales by Region
  9. 3.4.1 Global Endocrinology Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Endocrinology Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Endocrinology Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Endocrinology Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Endocrinology Drugs Revenue by Manufacturers
  2. 4.1.1 Global Endocrinology Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Endocrinology Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Endocrinology Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Endocrinology Drugs Sales by Manufacturers
  6. 4.2.1 Global Endocrinology Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Endocrinology Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Endocrinology Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Endocrinology Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Endocrinology Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Endocrinology Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Endocrinology Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Endocrinology Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Endocrinology Drugs Market CR5 and HHI
  16. 4.8.2 2025 Endocrinology Drugs Tier 1, Tier 2, and Tier 3
5 Endocrinology Drugs Market by Type
  1. 5.1 Global Endocrinology Drugs Revenue by Type
  2. 5.1.1 Global Endocrinology Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Endocrinology Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Endocrinology Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Endocrinology Drugs Sales by Type
  6. 5.2.1 Global Endocrinology Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Endocrinology Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Endocrinology Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Endocrinology Drugs Price by Type
6 Endocrinology Drugs Market by Application
  1. 6.1 Global Endocrinology Drugs Revenue by Application
  2. 6.1.1 Global Endocrinology Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Endocrinology Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Endocrinology Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Endocrinology Drugs Sales by Application
  6. 6.2.1 Global Endocrinology Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Endocrinology Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Endocrinology Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Endocrinology Drugs Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Endocrinology Drugs Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Novo Nordisk
  8. 7.2.1 Novo Nordisk Company Information
  9. 7.2.2 Novo Nordisk Business Overview
  10. 7.2.3 Novo Nordisk Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novo Nordisk Endocrinology Drugs Product Portfolio
  12. 7.2.5 Novo Nordisk Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Endocrinology Drugs Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Eli Lilly
  20. 7.4.1 Eli Lilly Company Information
  21. 7.4.2 Eli Lilly Business Overview
  22. 7.4.3 Eli Lilly Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly Endocrinology Drugs Product Portfolio
  24. 7.4.5 Eli Lilly Recent Developments
  25. 7.5 AbbVie
  26. 7.5.1 AbbVie Company Information
  27. 7.5.2 AbbVie Business Overview
  28. 7.5.3 AbbVie Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AbbVie Endocrinology Drugs Product Portfolio
  30. 7.5.5 AbbVie Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Endocrinology Drugs Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
8 North America
  1. 8.1 North America Endocrinology Drugs Market Size by Type
  2. 8.1.1 North America Endocrinology Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Endocrinology Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Endocrinology Drugs Price by Type (2021-2032)
  5. 8.2 North America Endocrinology Drugs Market Size by Application
  6. 8.2.1 North America Endocrinology Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Endocrinology Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Endocrinology Drugs Price by Application (2021-2032)
  9. 8.3 North America Endocrinology Drugs Market Size by Country
  10. 8.3.1 North America Endocrinology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Endocrinology Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Endocrinology Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Endocrinology Drugs Market Size by Type
  2. 9.1.1 Europe Endocrinology Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Endocrinology Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Endocrinology Drugs Price by Type (2021-2032)
  5. 9.2 Europe Endocrinology Drugs Market Size by Application
  6. 9.2.1 Europe Endocrinology Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Endocrinology Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Endocrinology Drugs Price by Application (2021-2032)
  9. 9.3 Europe Endocrinology Drugs Market Size by Country
  10. 9.3.1 Europe Endocrinology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Endocrinology Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Endocrinology Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Endocrinology Drugs Market Size by Type
  2. 10.1.1 China Endocrinology Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Endocrinology Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Endocrinology Drugs Price by Type (2021-2032)
  5. 10.2 China Endocrinology Drugs Market Size by Application
  6. 10.2.1 China Endocrinology Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Endocrinology Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Endocrinology Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Endocrinology Drugs Market Size by Type
  2. 11.1.1 Asia Endocrinology Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Endocrinology Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Endocrinology Drugs Price by Type (2021-2032)
  5. 11.2 Asia Endocrinology Drugs Market Size by Application
  6. 11.2.1 Asia Endocrinology Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Endocrinology Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Endocrinology Drugs Price by Application (2021-2032)
  9. 11.3 Asia Endocrinology Drugs Market Size by Country
  10. 11.3.1 Asia Endocrinology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Endocrinology Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Endocrinology Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Endocrinology Drugs Market Size by Type
  2. 12.1.1 SAMEA Endocrinology Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Endocrinology Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Endocrinology Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Endocrinology Drugs Market Size by Application
  6. 12.2.1 SAMEA Endocrinology Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Endocrinology Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Endocrinology Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Endocrinology Drugs Market Size by Country
  10. 12.3.1 SAMEA Endocrinology Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Endocrinology Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Endocrinology Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Endocrinology Drugs Value Chain Analysis
  2. 13.1.1 Endocrinology Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Endocrinology Drugs Production Mode & Process
  6. 13.2 Endocrinology Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Endocrinology Drugs Distributors
  9. 13.2.3 Endocrinology Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst